Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.
Pilgrim T., Piccolo R., Heg D., Roffi M., Tüller D., Muller O., Moarof I., Siontis GCM, Cook S., Weilenmann D. et al., 2018/09/01. Lancet, 392 (10149) pp. 737-746. Peer-reviewed.
ici le détail